Page last updated: 2024-10-30

ketotifen and Bruxism, Nocturnal

ketotifen has been researched along with Bruxism, Nocturnal in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Research Excerpts

ExcerptRelevanceReference
"Iatrogenic sleep bruxism has been described following treatment with several psychotropic medications."1.40Ketotifen-induced nocturnal bruxism. ( Bramanti, P; Calabro, RS; Italiano, D; Militi, D; Mondello, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Italiano, D1
Bramanti, P1
Militi, D1
Mondello, S1
Calabro, RS1

Other Studies

1 other study available for ketotifen and Bruxism, Nocturnal

ArticleYear
Ketotifen-induced nocturnal bruxism.
    European journal of pediatrics, 2014, Volume: 173, Issue:12

    Topics: Child, Preschool; Histamine H1 Antagonists; Humans; Ketotifen; Male; Sleep Bruxism

2014